Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 15, 2007Clinical Cancer ResearchOpen Access

A Divalent Hapten-Peptide Induces Apoptosis in Human Non–Hodgkin Lymphoma Cell Lines Targeted by Anti-CD20 × Anti-Hapten Bispecific Antibodies

View Full Paper
Ask AI
Bookmark
Share

Authors

PBPierre-Yves BrardHKHabibe KaracayCenter for Molecular Medicine and ImmunologyRSRhona SteinCenter for Molecular Medicine and Immunology

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Brard et al. (2007) studied this question.

synapsesocial.com/papers/6a73dbb15e45dc7750a8bdcahttps://doi.org/10.1158/1078-0432.ccr-07-1204
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts2001 · 149 citations
  2. 2Structural Changes of Mitochondria Related to Apoptosis2001 · 51 citations
  3. 3Bivalent Hapten-Bearing Peptides Designed for Iodine-131 Pretargeted Radioimmunotherapy1997 · 47 citations
  4. 4Apoptosis of Malignant Human B Cells by Ligation of CD20 With Monoclonal Antibodies1998 · 572 citations
  5. 5The Biologic Effects of C225, A Chimeric Monoclonal Antibody to the EGFR, on Human Prostate Carcinoma1996 · 245 citations